Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin R Taft

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Advanced Synthesis & Catalysis|March 25, 2014
Rhodium-Catalyzed Asymmetric 1,4-Additions, in Water at Room Temperature, with In-Flask Catalyst RecyclingBruce H Lipshutz, Nicholas A Isley, Ralph Moser, et al.
The Journal of Organic Chemistry|May 5, 2011
Manipulating micellar environments for enhancing transition metal-catalyzed cross-couplings in water at room temperatureBruce H Lipshutz, Subir Ghorai, Wendy Wen Yi Leong, et al.
Chemistry, an Asian Journal|April 19, 2007
Microwave-assisted heterogeneous cross-coupling reactions catalyzed by nickel-in-charcoal (Ni/C)Bruce H Lipshutz, Bryan A Frieman, Ching-Tien Lee, et al.
Journal of Medicinal Chemistry|July 23, 2025
Discovery and Optimization of a Novel Series of Influenza A Virus Replication Inhibitors Targeting the Nucleoprotein Protein-Protein InteractionBenjamin R Taft, Matthew J Hesse, Mulugeta Mamo, et al.
Antimicrobial Agents and Chemotherapy|December 19, 2025
Identification and characterization of a novel inhibitor of influenza A virus that acts by blocking nucleoprotein oligomerizationVincent H J Leonard, Dianna B Vidales, Benjamin R Taft, et al.
Journal of Medicinal Chemistry|May 31, 2017
Design and Discovery of N-(2-Methyl-5'-morpholino-6'-((tetrahydro-2H-pyran-4-yl)oxy)-[3,3'-bipyridin]-5-yl)-3-(trifluoromethyl)benzamide (RAF709): A Potent, Selective, and Efficacious RAF Inhibitor Targeting RAS Mutant CancersGisele A Nishiguchi, Alice Rico, Huw Tanner, et al.
Journal of Medicinal Chemistry|March 1, 2022
Discovery and Preclinical Pharmacology of INE963, a Potent and Fast-Acting Blood-Stage Antimalarial with a High Barrier to Resistance and Potential for Single-Dose Cures in Uncomplicated MalariaBenjamin R Taft, Fumiaki Yokokawa, Tom Kirrane, et al.
Journal of Medicinal Chemistry|May 7, 2019
Design and Discovery of <i>N</i>-(3-(2-(2-Hydroxyethoxy)-6-morpholinopyridin-4-yl)-4-methylphenyl)-2-(trifluoromethyl)isonicotinamide, a Selective, Efficacious, and Well-Tolerated RAF Inhibitor Targeting RAS Mutant Cancers: The Path to the ClinicSavithri Ramurthy, Benjamin R Taft, Robert J Aversa, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Advanced Synthesis & Catalysis|March 25, 2014
Rhodium-Catalyzed Asymmetric 1,4-Additions, in Water at Room Temperature, with In-Flask Catalyst RecyclingBruce H Lipshutz, Nicholas A Isley, Ralph Moser, et al.
The Journal of Organic Chemistry|May 5, 2011
Manipulating micellar environments for enhancing transition metal-catalyzed cross-couplings in water at room temperatureBruce H Lipshutz, Subir Ghorai, Wendy Wen Yi Leong, et al.
Chemistry, an Asian Journal|April 19, 2007
Microwave-assisted heterogeneous cross-coupling reactions catalyzed by nickel-in-charcoal (Ni/C)Bruce H Lipshutz, Bryan A Frieman, Ching-Tien Lee, et al.
Journal of Medicinal Chemistry|July 23, 2025
Discovery and Optimization of a Novel Series of Influenza A Virus Replication Inhibitors Targeting the Nucleoprotein Protein-Protein InteractionBenjamin R Taft, Matthew J Hesse, Mulugeta Mamo, et al.
Antimicrobial Agents and Chemotherapy|December 19, 2025
Identification and characterization of a novel inhibitor of influenza A virus that acts by blocking nucleoprotein oligomerizationVincent H J Leonard, Dianna B Vidales, Benjamin R Taft, et al.
Journal of Medicinal Chemistry|May 31, 2017
Design and Discovery of N-(2-Methyl-5'-morpholino-6'-((tetrahydro-2H-pyran-4-yl)oxy)-[3,3'-bipyridin]-5-yl)-3-(trifluoromethyl)benzamide (RAF709): A Potent, Selective, and Efficacious RAF Inhibitor Targeting RAS Mutant CancersGisele A Nishiguchi, Alice Rico, Huw Tanner, et al.
Journal of Medicinal Chemistry|March 1, 2022
Discovery and Preclinical Pharmacology of INE963, a Potent and Fast-Acting Blood-Stage Antimalarial with a High Barrier to Resistance and Potential for Single-Dose Cures in Uncomplicated MalariaBenjamin R Taft, Fumiaki Yokokawa, Tom Kirrane, et al.
Journal of Medicinal Chemistry|May 7, 2019
Design and Discovery of <i>N</i>-(3-(2-(2-Hydroxyethoxy)-6-morpholinopyridin-4-yl)-4-methylphenyl)-2-(trifluoromethyl)isonicotinamide, a Selective, Efficacious, and Well-Tolerated RAF Inhibitor Targeting RAS Mutant Cancers: The Path to the ClinicSavithri Ramurthy, Benjamin R Taft, Robert J Aversa, et al.
Pageof 2